0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Point of Care Rapid Diagnosis Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-7G13726
Home | Market Reports | Health| Medical Facilities & Services
Global Point of Care Rapid Diagnosis Market Research Report 2023
BUY CHAPTERS

Global Point of Care Rapid Diagnosis Market Research Report 2025

Code: QYRE-Auto-7G13726
Report
January 2025
Pages:112
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Point of Care Rapid Diagnosis Market Size

The global market for Point of Care Rapid Diagnosis was valued at US$ 46360 million in the year 2024 and is projected to reach a revised size of US$ 69310 million by 2031, growing at a CAGR of 6.0% during the forecast period.

Point of Care Rapid Diagnosis Market

Point of Care Rapid Diagnosis Market

Point of Care Rapid Diagnosis is defined as medical diagnostic testing at or near the point of care—that is, at the time and place of patient care.This contrasts with the historical pattern in which testing was wholly or mostly confined to the medical laboratory, which entailed sending off specimens away from the point of care and then waiting hours or days to learn the results. The driving notion behind Point of Care Rapid Diagnosis is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for better immediate clinical management decisions to be made. Point of Care Rapid Diagnosis includes: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing, rapid cardiac markers diagnostics, drugs of abuse screening, Sepsis Testing, Upper Respiratory Tract Infections Testing, Antibiotic Resistance Testing, food pathogens screening, hemoglobin diagnostics, infectious disease testing and cholesterol screening. Point of Care Rapid Diagnosis is often accomplished through the use of transportable, portable, and handheld instruments and test kits.Small bench analyzers or fixed equipment can also be used when a handheld device is not available—the goal is to collect the specimen and obtain the results in a very short period of time at or near the location of the patient so that the treatment plan can be adjusted as necessary before the patient leaves.Cheaper, faster, and smarter Point of Care Rapid Diagnosis devices have increased the use of Point of Care Rapid Diagnosis approaches by making it cost-effective for many diseases.
The global point of care rapid diagnosis market refers to the market for diagnostic tests and devices that can provide immediate results at the patient’s bedside or in close proximity to the patient. These tests are designed to offer timely and accurate diagnostic information, enabling healthcare providers to make informed treatment decisions quickly.
Here are some key features and trends in the global point of care rapid diagnosis market:
Growing Demand for Quick and Accurate Diagnostic Solutions: There is a rising demand for rapid diagnostic tests that can provide immediate results, especially in emergency and critical care settings. These tests allow healthcare professionals to diagnose and initiate appropriate treatment promptly, reducing the time to diagnosis and improving patient outcomes.
Wide Range of Applications: Point of care rapid diagnosis tests are used across various medical specialties, including infectious diseases, cardiovascular diseases, respiratory diseases, oncology, diabetes, pregnancy, and drug testing. The market offers a range of rapid tests such as immunoassays, molecular diagnostics, lateral flow assays, and biosensors to cater to specific diagnostic needs.
Technological Advancements: The market is witnessing continuous advancements in technology, leading to the development of more accurate and user-friendly rapid diagnostic devices. These advancements include miniaturization of devices, incorporation of biosensors, integration with smartphones or handheld devices, and the use of lab-on-a-chip technology. These innovations enable faster and more precise diagnostic testing.
Infectious Disease Diagnosis: Rapid diagnosis of infectious diseases, especially in resource-limited settings, is a significant focus area within the global point of care rapid diagnosis market. Rapid tests for infectious diseases such as COVID-19, HIV, malaria, tuberculosis, and hepatitis are widely used to facilitate early diagnosis, screening, and monitoring of patients.
Home-based Testing: The market is witnessing a growing trend of point of care rapid diagnosis tests conducted by patients themselves at home. Home-based testing kits for pregnancy, glucose monitoring, cholesterol testing, and sexually transmitted infections are increasingly available, empowering individuals to monitor their health and take appropriate actions.
Integration with Electronic Health Records (EHR): Integration of point of care rapid diagnosis devices with electronic health records systems is gaining prominence. This integration enables real-time data capture, automatic updating of patient records, and seamless sharing of test results with healthcare providers. It enhances data management, reduces documentation errors, and facilitates efficient and coordinated care.
Regulatory Considerations: Regulatory bodies play a crucial role in the point of care rapid diagnosis market. Authorities like the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and other regional agencies provide guidelines and regulations for the development, approval, and marketing of rapid diagnostic tests. Compliance with regulatory requirements ensures the safety, quality, and effectiveness of these tests.
The global point of care rapid diagnosis market is expected to witness substantial growth in the coming years due to the increasing demand for quick and accurate diagnostic solutions, advancements in technology, and the need for decentralized diagnostic testing. The market’s expansion is driven by the potential to improve patient outcomes, reduce healthcare costs, and enhance the accessibility of diagnostic services.The global point of care rapid diagnosis market refers to the market for diagnostic tests and devices that can provide immediate results at the patient’s bedside or in close proximity to the patient. These tests are designed to offer timely and accurate diagnostic information, enabling healthcare providers to make informed treatment decisions quickly.
Here are some key features and trends in the global point of care rapid diagnosis market:
Growing Demand for Quick and Accurate Diagnostic Solutions: There is a rising demand for rapid diagnostic tests that can provide immediate results, especially in emergency and critical care settings. These tests allow healthcare professionals to diagnose and initiate appropriate treatment promptly, reducing the time to diagnosis and improving patient outcomes.
Wide Range of Applications: Point of care rapid diagnosis tests are used across various medical specialties, including infectious diseases, cardiovascular diseases, respiratory diseases, oncology, diabetes, pregnancy, and drug testing. The market offers a range of rapid tests such as immunoassays, molecular diagnostics, lateral flow assays, and biosensors to cater to specific diagnostic needs.
Technological Advancements: The market is witnessing continuous advancements in technology, leading to the development of more accurate and user-friendly rapid diagnostic devices. These advancements include miniaturization of devices, incorporation of biosensors, integration with smartphones or handheld devices, and the use of lab-on-a-chip technology. These innovations enable faster and more precise diagnostic testing.
Infectious Disease Diagnosis: Rapid diagnosis of infectious diseases, especially in resource-limited settings, is a significant focus area within the global point of care rapid diagnosis market. Rapid tests for infectious diseases such as COVID-19, HIV, malaria, tuberculosis, and hepatitis are widely used to facilitate early diagnosis, screening, and monitoring of patients.
Home-based Testing: The market is witnessing a growing trend of point of care rapid diagnosis tests conducted by patients themselves at home. Home-based testing kits for pregnancy, glucose monitoring, cholesterol testing, and sexually transmitted infections are increasingly available, empowering individuals to monitor their health and take appropriate actions.
Integration with Electronic Health Records (EHR): Integration of point of care rapid diagnosis devices with electronic health records systems is gaining prominence. This integration enables real-time data capture, automatic updating of patient records, and seamless sharing of test results with healthcare providers. It enhances data management, reduces documentation errors, and facilitates efficient and coordinated care.
Regulatory Considerations: Regulatory bodies play a crucial role in the point of care rapid diagnosis market. Authorities like the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and other regional agencies provide guidelines and regulations for the development, approval, and marketing of rapid diagnostic tests. Compliance with regulatory requirements ensures the safety, quality, and effectiveness of these tests.
The global point of care rapid diagnosis market is expected to witness substantial growth in the coming years due to the increasing demand for quick and accurate diagnostic solutions, advancements in technology, and the need for decentralized diagnostic testing. The market’s expansion is driven by the potential to improve patient outcomes, reduce healthcare costs, and enhance the accessibility of diagnostic services.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Point of Care Rapid Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Point of Care Rapid Diagnosis.
The Point of Care Rapid Diagnosis market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Point of Care Rapid Diagnosis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Point of Care Rapid Diagnosis manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Point of Care Rapid Diagnosis Market Report

Report Metric Details
Report Name Point of Care Rapid Diagnosis Market
Accounted market size in year US$ 46360 million
Forecasted market size in 2031 US$ 69310 million
CAGR 6.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Blood Glucose Testing
  • Blood Gas and Electrolytes Analysis
  • Rapid Coagulation Testing
  • Rapid Cardiac Markers Diagnostic
  • Drugs of Abuse Screening
  • Food Pathogens Screening
  • Hemoglobin Diagnostics
  • Infectious Disease Testing
  • Others
Segment by Application
  • Clinics
  • Hospitals
  • Laboratory
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Roche, Abbott, Johnson & Johnson, Siemens Healthcare, Danaher, Ascensia, Bio-Rad Laboratories, BioMerieux, Nova Biomedical, Trividia Health, Quidel, Accriva, OraSure Technologies, Helena Laboratories, A. Menarini Diagnostics, Abaxis (Zoetis), Ortho Clinical Diagnostics, Phamatech, Chembio Diagnostics, Trinity Biotech, ELITech Group, Response Biomedical, Princeton BioMeditech, Alfa Wassermann, ARKRAY
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Point of Care Rapid Diagnosis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Point of Care Rapid Diagnosis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Point of Care Rapid Diagnosis Market growing?

Ans: The Point of Care Rapid Diagnosis Market witnessing a CAGR of 6.0% during the forecast period 2025-2031.

What is the Point of Care Rapid Diagnosis Market size in 2031?

Ans: The Point of Care Rapid Diagnosis Market size in 2031 will be US$ 69310 million.

Who are the main players in the Point of Care Rapid Diagnosis Market report?

Ans: The main players in the Point of Care Rapid Diagnosis Market are Roche, Abbott, Johnson & Johnson, Siemens Healthcare, Danaher, Ascensia, Bio-Rad Laboratories, BioMerieux, Nova Biomedical, Trividia Health, Quidel, Accriva, OraSure Technologies, Helena Laboratories, A. Menarini Diagnostics, Abaxis (Zoetis), Ortho Clinical Diagnostics, Phamatech, Chembio Diagnostics, Trinity Biotech, ELITech Group, Response Biomedical, Princeton BioMeditech, Alfa Wassermann, ARKRAY

What are the Application segmentation covered in the Point of Care Rapid Diagnosis Market report?

Ans: The Applications covered in the Point of Care Rapid Diagnosis Market report are Clinics, Hospitals, Laboratory, Others

What are the Type segmentation covered in the Point of Care Rapid Diagnosis Market report?

Ans: The Types covered in the Point of Care Rapid Diagnosis Market report are Blood Glucose Testing, Blood Gas and Electrolytes Analysis, Rapid Coagulation Testing, Rapid Cardiac Markers Diagnostic, Drugs of Abuse Screening, Food Pathogens Screening, Hemoglobin Diagnostics, Infectious Disease Testing, Others

Recommended Reports

Point of Care Diagnostics

Rapid Diagnostic Testing

Portable Analyzers & Kits

1 Point of Care Rapid Diagnosis Market Overview
1.1 Product Definition
1.2 Point of Care Rapid Diagnosis by Type
1.2.1 Global Point of Care Rapid Diagnosis Market Value Comparison by Type (2024 VS 2031)
1.2.2 Blood Glucose Testing
1.2.3 Blood Gas and Electrolytes Analysis
1.2.4 Rapid Coagulation Testing
1.2.5 Rapid Cardiac Markers Diagnostic
1.2.6 Drugs of Abuse Screening
1.2.7 Food Pathogens Screening
1.2.8 Hemoglobin Diagnostics
1.2.9 Infectious Disease Testing
1.2.10 Others
1.3 Point of Care Rapid Diagnosis by Application
1.3.1 Global Point of Care Rapid Diagnosis Market Value by Application (2024 VS 2031)
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Laboratory
1.3.5 Others
1.4 Global Point of Care Rapid Diagnosis Market Size Estimates and Forecasts
1.4.1 Global Point of Care Rapid Diagnosis Revenue 2020-2031
1.4.2 Global Point of Care Rapid Diagnosis Sales 2020-2031
1.4.3 Global Point of Care Rapid Diagnosis Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Point of Care Rapid Diagnosis Market Competition by Manufacturers
2.1 Global Point of Care Rapid Diagnosis Sales Market Share by Manufacturers (2020-2025)
2.2 Global Point of Care Rapid Diagnosis Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Point of Care Rapid Diagnosis Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Point of Care Rapid Diagnosis, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Point of Care Rapid Diagnosis, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Point of Care Rapid Diagnosis, Product Type & Application
2.7 Global Key Manufacturers of Point of Care Rapid Diagnosis, Date of Enter into This Industry
2.8 Global Point of Care Rapid Diagnosis Market Competitive Situation and Trends
2.8.1 Global Point of Care Rapid Diagnosis Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Point of Care Rapid Diagnosis Players Market Share by Revenue
2.8.3 Global Point of Care Rapid Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Point of Care Rapid Diagnosis Market Scenario by Region
3.1 Global Point of Care Rapid Diagnosis Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Point of Care Rapid Diagnosis Sales by Region: 2020-2031
3.2.1 Global Point of Care Rapid Diagnosis Sales by Region: 2020-2025
3.2.2 Global Point of Care Rapid Diagnosis Sales by Region: 2026-2031
3.3 Global Point of Care Rapid Diagnosis Revenue by Region: 2020-2031
3.3.1 Global Point of Care Rapid Diagnosis Revenue by Region: 2020-2025
3.3.2 Global Point of Care Rapid Diagnosis Revenue by Region: 2026-2031
3.4 North America Point of Care Rapid Diagnosis Market Facts & Figures by Country
3.4.1 North America Point of Care Rapid Diagnosis Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Point of Care Rapid Diagnosis Sales by Country (2020-2031)
3.4.3 North America Point of Care Rapid Diagnosis Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Point of Care Rapid Diagnosis Market Facts & Figures by Country
3.5.1 Europe Point of Care Rapid Diagnosis Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Point of Care Rapid Diagnosis Sales by Country (2020-2031)
3.5.3 Europe Point of Care Rapid Diagnosis Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Point of Care Rapid Diagnosis Market Facts & Figures by Region
3.6.1 Asia Pacific Point of Care Rapid Diagnosis Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Point of Care Rapid Diagnosis Sales by Region (2020-2031)
3.6.3 Asia Pacific Point of Care Rapid Diagnosis Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Point of Care Rapid Diagnosis Market Facts & Figures by Country
3.7.1 Latin America Point of Care Rapid Diagnosis Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Point of Care Rapid Diagnosis Sales by Country (2020-2031)
3.7.3 Latin America Point of Care Rapid Diagnosis Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Point of Care Rapid Diagnosis Market Facts & Figures by Country
3.8.1 Middle East and Africa Point of Care Rapid Diagnosis Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Point of Care Rapid Diagnosis Sales by Country (2020-2031)
3.8.3 Middle East and Africa Point of Care Rapid Diagnosis Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Point of Care Rapid Diagnosis Sales by Type (2020-2031)
4.1.1 Global Point of Care Rapid Diagnosis Sales by Type (2020-2025)
4.1.2 Global Point of Care Rapid Diagnosis Sales by Type (2026-2031)
4.1.3 Global Point of Care Rapid Diagnosis Sales Market Share by Type (2020-2031)
4.2 Global Point of Care Rapid Diagnosis Revenue by Type (2020-2031)
4.2.1 Global Point of Care Rapid Diagnosis Revenue by Type (2020-2025)
4.2.2 Global Point of Care Rapid Diagnosis Revenue by Type (2026-2031)
4.2.3 Global Point of Care Rapid Diagnosis Revenue Market Share by Type (2020-2031)
4.3 Global Point of Care Rapid Diagnosis Price by Type (2020-2031)
5 Segment by Application
5.1 Global Point of Care Rapid Diagnosis Sales by Application (2020-2031)
5.1.1 Global Point of Care Rapid Diagnosis Sales by Application (2020-2025)
5.1.2 Global Point of Care Rapid Diagnosis Sales by Application (2026-2031)
5.1.3 Global Point of Care Rapid Diagnosis Sales Market Share by Application (2020-2031)
5.2 Global Point of Care Rapid Diagnosis Revenue by Application (2020-2031)
5.2.1 Global Point of Care Rapid Diagnosis Revenue by Application (2020-2025)
5.2.2 Global Point of Care Rapid Diagnosis Revenue by Application (2026-2031)
5.2.3 Global Point of Care Rapid Diagnosis Revenue Market Share by Application (2020-2031)
5.3 Global Point of Care Rapid Diagnosis Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Point of Care Rapid Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Roche Point of Care Rapid Diagnosis Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Abbott
6.2.1 Abbott Company Information
6.2.2 Abbott Description and Business Overview
6.2.3 Abbott Point of Care Rapid Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Abbott Point of Care Rapid Diagnosis Product Portfolio
6.2.5 Abbott Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Company Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Point of Care Rapid Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Johnson & Johnson Point of Care Rapid Diagnosis Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Siemens Healthcare
6.4.1 Siemens Healthcare Company Information
6.4.2 Siemens Healthcare Description and Business Overview
6.4.3 Siemens Healthcare Point of Care Rapid Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Siemens Healthcare Point of Care Rapid Diagnosis Product Portfolio
6.4.5 Siemens Healthcare Recent Developments/Updates
6.5 Danaher
6.5.1 Danaher Company Information
6.5.2 Danaher Description and Business Overview
6.5.3 Danaher Point of Care Rapid Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Danaher Point of Care Rapid Diagnosis Product Portfolio
6.5.5 Danaher Recent Developments/Updates
6.6 Ascensia
6.6.1 Ascensia Company Information
6.6.2 Ascensia Description and Business Overview
6.6.3 Ascensia Point of Care Rapid Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Ascensia Point of Care Rapid Diagnosis Product Portfolio
6.6.5 Ascensia Recent Developments/Updates
6.7 Bio-Rad Laboratories
6.7.1 Bio-Rad Laboratories Company Information
6.7.2 Bio-Rad Laboratories Description and Business Overview
6.7.3 Bio-Rad Laboratories Point of Care Rapid Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Bio-Rad Laboratories Point of Care Rapid Diagnosis Product Portfolio
6.7.5 Bio-Rad Laboratories Recent Developments/Updates
6.8 BioMerieux
6.8.1 BioMerieux Company Information
6.8.2 BioMerieux Description and Business Overview
6.8.3 BioMerieux Point of Care Rapid Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.8.4 BioMerieux Point of Care Rapid Diagnosis Product Portfolio
6.8.5 BioMerieux Recent Developments/Updates
6.9 Nova Biomedical
6.9.1 Nova Biomedical Company Information
6.9.2 Nova Biomedical Description and Business Overview
6.9.3 Nova Biomedical Point of Care Rapid Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Nova Biomedical Point of Care Rapid Diagnosis Product Portfolio
6.9.5 Nova Biomedical Recent Developments/Updates
6.10 Trividia Health
6.10.1 Trividia Health Company Information
6.10.2 Trividia Health Description and Business Overview
6.10.3 Trividia Health Point of Care Rapid Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Trividia Health Point of Care Rapid Diagnosis Product Portfolio
6.10.5 Trividia Health Recent Developments/Updates
6.11 Quidel
6.11.1 Quidel Company Information
6.11.2 Quidel Description and Business Overview
6.11.3 Quidel Point of Care Rapid Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Quidel Point of Care Rapid Diagnosis Product Portfolio
6.11.5 Quidel Recent Developments/Updates
6.12 Accriva
6.12.1 Accriva Company Information
6.12.2 Accriva Description and Business Overview
6.12.3 Accriva Point of Care Rapid Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Accriva Point of Care Rapid Diagnosis Product Portfolio
6.12.5 Accriva Recent Developments/Updates
6.13 OraSure Technologies
6.13.1 OraSure Technologies Company Information
6.13.2 OraSure Technologies Description and Business Overview
6.13.3 OraSure Technologies Point of Care Rapid Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.13.4 OraSure Technologies Point of Care Rapid Diagnosis Product Portfolio
6.13.5 OraSure Technologies Recent Developments/Updates
6.14 Helena Laboratories
6.14.1 Helena Laboratories Company Information
6.14.2 Helena Laboratories Description and Business Overview
6.14.3 Helena Laboratories Point of Care Rapid Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Helena Laboratories Point of Care Rapid Diagnosis Product Portfolio
6.14.5 Helena Laboratories Recent Developments/Updates
6.15 A. Menarini Diagnostics
6.15.1 A. Menarini Diagnostics Company Information
6.15.2 A. Menarini Diagnostics Description and Business Overview
6.15.3 A. Menarini Diagnostics Point of Care Rapid Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.15.4 A. Menarini Diagnostics Point of Care Rapid Diagnosis Product Portfolio
6.15.5 A. Menarini Diagnostics Recent Developments/Updates
6.16 Abaxis (Zoetis)
6.16.1 Abaxis (Zoetis) Company Information
6.16.2 Abaxis (Zoetis) Description and Business Overview
6.16.3 Abaxis (Zoetis) Point of Care Rapid Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Abaxis (Zoetis) Point of Care Rapid Diagnosis Product Portfolio
6.16.5 Abaxis (Zoetis) Recent Developments/Updates
6.17 Ortho Clinical Diagnostics
6.17.1 Ortho Clinical Diagnostics Company Information
6.17.2 Ortho Clinical Diagnostics Description and Business Overview
6.17.3 Ortho Clinical Diagnostics Point of Care Rapid Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Ortho Clinical Diagnostics Point of Care Rapid Diagnosis Product Portfolio
6.17.5 Ortho Clinical Diagnostics Recent Developments/Updates
6.18 Phamatech
6.18.1 Phamatech Company Information
6.18.2 Phamatech Description and Business Overview
6.18.3 Phamatech Point of Care Rapid Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Phamatech Point of Care Rapid Diagnosis Product Portfolio
6.18.5 Phamatech Recent Developments/Updates
6.19 Chembio Diagnostics
6.19.1 Chembio Diagnostics Company Information
6.19.2 Chembio Diagnostics Description and Business Overview
6.19.3 Chembio Diagnostics Point of Care Rapid Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Chembio Diagnostics Point of Care Rapid Diagnosis Product Portfolio
6.19.5 Chembio Diagnostics Recent Developments/Updates
6.20 Trinity Biotech
6.20.1 Trinity Biotech Company Information
6.20.2 Trinity Biotech Description and Business Overview
6.20.3 Trinity Biotech Point of Care Rapid Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Trinity Biotech Point of Care Rapid Diagnosis Product Portfolio
6.20.5 Trinity Biotech Recent Developments/Updates
6.21 ELITech Group
6.21.1 ELITech Group Company Information
6.21.2 ELITech Group Description and Business Overview
6.21.3 ELITech Group Point of Care Rapid Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.21.4 ELITech Group Point of Care Rapid Diagnosis Product Portfolio
6.21.5 ELITech Group Recent Developments/Updates
6.22 Response Biomedical
6.22.1 Response Biomedical Company Information
6.22.2 Response Biomedical Description and Business Overview
6.22.3 Response Biomedical Point of Care Rapid Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Response Biomedical Point of Care Rapid Diagnosis Product Portfolio
6.22.5 Response Biomedical Recent Developments/Updates
6.23 Princeton BioMeditech
6.23.1 Princeton BioMeditech Company Information
6.23.2 Princeton BioMeditech Description and Business Overview
6.23.3 Princeton BioMeditech Point of Care Rapid Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.23.4 Princeton BioMeditech Point of Care Rapid Diagnosis Product Portfolio
6.23.5 Princeton BioMeditech Recent Developments/Updates
6.24 Alfa Wassermann
6.24.1 Alfa Wassermann Company Information
6.24.2 Alfa Wassermann Description and Business Overview
6.24.3 Alfa Wassermann Point of Care Rapid Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.24.4 Alfa Wassermann Point of Care Rapid Diagnosis Product Portfolio
6.24.5 Alfa Wassermann Recent Developments/Updates
6.25 ARKRAY
6.25.1 ARKRAY Company Information
6.25.2 ARKRAY Description and Business Overview
6.25.3 ARKRAY Point of Care Rapid Diagnosis Sales, Revenue and Gross Margin (2020-2025)
6.25.4 ARKRAY Point of Care Rapid Diagnosis Product Portfolio
6.25.5 ARKRAY Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Point of Care Rapid Diagnosis Industry Chain Analysis
7.2 Point of Care Rapid Diagnosis Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Point of Care Rapid Diagnosis Production Mode & Process Analysis
7.4 Point of Care Rapid Diagnosis Sales and Marketing
7.4.1 Point of Care Rapid Diagnosis Sales Channels
7.4.2 Point of Care Rapid Diagnosis Distributors
7.5 Point of Care Rapid Diagnosis Customer Analysis
8 Point of Care Rapid Diagnosis Market Dynamics
8.1 Point of Care Rapid Diagnosis Industry Trends
8.2 Point of Care Rapid Diagnosis Market Drivers
8.3 Point of Care Rapid Diagnosis Market Challenges
8.4 Point of Care Rapid Diagnosis Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Point of Care Rapid Diagnosis Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Point of Care Rapid Diagnosis Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Point of Care Rapid Diagnosis Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Point of Care Rapid Diagnosis Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Point of Care Rapid Diagnosis Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Point of Care Rapid Diagnosis Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Point of Care Rapid Diagnosis Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Point of Care Rapid Diagnosis Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Point of Care Rapid Diagnosis, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Point of Care Rapid Diagnosis, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Point of Care Rapid Diagnosis, Product Type & Application
 Table 12. Global Key Manufacturers of Point of Care Rapid Diagnosis, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Point of Care Rapid Diagnosis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point of Care Rapid Diagnosis as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Point of Care Rapid Diagnosis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Point of Care Rapid Diagnosis Sales by Region (2020-2025) & (K Units)
 Table 18. Global Point of Care Rapid Diagnosis Sales Market Share by Region (2020-2025)
 Table 19. Global Point of Care Rapid Diagnosis Sales by Region (2026-2031) & (K Units)
 Table 20. Global Point of Care Rapid Diagnosis Sales Market Share by Region (2026-2031)
 Table 21. Global Point of Care Rapid Diagnosis Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Point of Care Rapid Diagnosis Revenue Market Share by Region (2020-2025)
 Table 23. Global Point of Care Rapid Diagnosis Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Point of Care Rapid Diagnosis Revenue Market Share by Region (2026-2031)
 Table 25. North America Point of Care Rapid Diagnosis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Point of Care Rapid Diagnosis Sales by Country (2020-2025) & (K Units)
 Table 27. North America Point of Care Rapid Diagnosis Sales by Country (2026-2031) & (K Units)
 Table 28. North America Point of Care Rapid Diagnosis Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Point of Care Rapid Diagnosis Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Point of Care Rapid Diagnosis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Point of Care Rapid Diagnosis Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Point of Care Rapid Diagnosis Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Point of Care Rapid Diagnosis Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Point of Care Rapid Diagnosis Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Point of Care Rapid Diagnosis Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Point of Care Rapid Diagnosis Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Point of Care Rapid Diagnosis Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Point of Care Rapid Diagnosis Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Point of Care Rapid Diagnosis Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Point of Care Rapid Diagnosis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Point of Care Rapid Diagnosis Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Point of Care Rapid Diagnosis Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Point of Care Rapid Diagnosis Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Point of Care Rapid Diagnosis Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Point of Care Rapid Diagnosis Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Point of Care Rapid Diagnosis Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Point of Care Rapid Diagnosis Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Point of Care Rapid Diagnosis Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Point of Care Rapid Diagnosis Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Point of Care Rapid Diagnosis Sales (K Units) by Type (2020-2025)
 Table 51. Global Point of Care Rapid Diagnosis Sales (K Units) by Type (2026-2031)
 Table 52. Global Point of Care Rapid Diagnosis Sales Market Share by Type (2020-2025)
 Table 53. Global Point of Care Rapid Diagnosis Sales Market Share by Type (2026-2031)
 Table 54. Global Point of Care Rapid Diagnosis Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Point of Care Rapid Diagnosis Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Point of Care Rapid Diagnosis Revenue Market Share by Type (2020-2025)
 Table 57. Global Point of Care Rapid Diagnosis Revenue Market Share by Type (2026-2031)
 Table 58. Global Point of Care Rapid Diagnosis Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Point of Care Rapid Diagnosis Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Point of Care Rapid Diagnosis Sales (K Units) by Application (2020-2025)
 Table 61. Global Point of Care Rapid Diagnosis Sales (K Units) by Application (2026-2031)
 Table 62. Global Point of Care Rapid Diagnosis Sales Market Share by Application (2020-2025)
 Table 63. Global Point of Care Rapid Diagnosis Sales Market Share by Application (2026-2031)
 Table 64. Global Point of Care Rapid Diagnosis Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Point of Care Rapid Diagnosis Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Point of Care Rapid Diagnosis Revenue Market Share by Application (2020-2025)
 Table 67. Global Point of Care Rapid Diagnosis Revenue Market Share by Application (2026-2031)
 Table 68. Global Point of Care Rapid Diagnosis Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Point of Care Rapid Diagnosis Price (US$/Unit) by Application (2026-2031)
 Table 70. Roche Company Information
 Table 71. Roche Description and Business Overview
 Table 72. Roche Point of Care Rapid Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Roche Point of Care Rapid Diagnosis Product
 Table 74. Roche Recent Developments/Updates
 Table 75. Abbott Company Information
 Table 76. Abbott Description and Business Overview
 Table 77. Abbott Point of Care Rapid Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Abbott Point of Care Rapid Diagnosis Product
 Table 79. Abbott Recent Developments/Updates
 Table 80. Johnson & Johnson Company Information
 Table 81. Johnson & Johnson Description and Business Overview
 Table 82. Johnson & Johnson Point of Care Rapid Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Johnson & Johnson Point of Care Rapid Diagnosis Product
 Table 84. Johnson & Johnson Recent Developments/Updates
 Table 85. Siemens Healthcare Company Information
 Table 86. Siemens Healthcare Description and Business Overview
 Table 87. Siemens Healthcare Point of Care Rapid Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Siemens Healthcare Point of Care Rapid Diagnosis Product
 Table 89. Siemens Healthcare Recent Developments/Updates
 Table 90. Danaher Company Information
 Table 91. Danaher Description and Business Overview
 Table 92. Danaher Point of Care Rapid Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Danaher Point of Care Rapid Diagnosis Product
 Table 94. Danaher Recent Developments/Updates
 Table 95. Ascensia Company Information
 Table 96. Ascensia Description and Business Overview
 Table 97. Ascensia Point of Care Rapid Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Ascensia Point of Care Rapid Diagnosis Product
 Table 99. Ascensia Recent Developments/Updates
 Table 100. Bio-Rad Laboratories Company Information
 Table 101. Bio-Rad Laboratories Description and Business Overview
 Table 102. Bio-Rad Laboratories Point of Care Rapid Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Bio-Rad Laboratories Point of Care Rapid Diagnosis Product
 Table 104. Bio-Rad Laboratories Recent Developments/Updates
 Table 105. BioMerieux Company Information
 Table 106. BioMerieux Description and Business Overview
 Table 107. BioMerieux Point of Care Rapid Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. BioMerieux Point of Care Rapid Diagnosis Product
 Table 109. BioMerieux Recent Developments/Updates
 Table 110. Nova Biomedical Company Information
 Table 111. Nova Biomedical Description and Business Overview
 Table 112. Nova Biomedical Point of Care Rapid Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Nova Biomedical Point of Care Rapid Diagnosis Product
 Table 114. Nova Biomedical Recent Developments/Updates
 Table 115. Trividia Health Company Information
 Table 116. Trividia Health Description and Business Overview
 Table 117. Trividia Health Point of Care Rapid Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Trividia Health Point of Care Rapid Diagnosis Product
 Table 119. Trividia Health Recent Developments/Updates
 Table 120. Quidel Company Information
 Table 121. Quidel Description and Business Overview
 Table 122. Quidel Point of Care Rapid Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Quidel Point of Care Rapid Diagnosis Product
 Table 124. Quidel Recent Developments/Updates
 Table 125. Accriva Company Information
 Table 126. Accriva Description and Business Overview
 Table 127. Accriva Point of Care Rapid Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Accriva Point of Care Rapid Diagnosis Product
 Table 129. Accriva Recent Developments/Updates
 Table 130. OraSure Technologies Company Information
 Table 131. OraSure Technologies Description and Business Overview
 Table 132. OraSure Technologies Point of Care Rapid Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. OraSure Technologies Point of Care Rapid Diagnosis Product
 Table 134. OraSure Technologies Recent Developments/Updates
 Table 135. Helena Laboratories Company Information
 Table 136. Helena Laboratories Description and Business Overview
 Table 137. Helena Laboratories Point of Care Rapid Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Helena Laboratories Point of Care Rapid Diagnosis Product
 Table 139. Helena Laboratories Recent Developments/Updates
 Table 140. A. Menarini Diagnostics Company Information
 Table 141. A. Menarini Diagnostics Description and Business Overview
 Table 142. A. Menarini Diagnostics Point of Care Rapid Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. A. Menarini Diagnostics Point of Care Rapid Diagnosis Product
 Table 144. A. Menarini Diagnostics Recent Developments/Updates
 Table 145. Abaxis (Zoetis) Company Information
 Table 146. Abaxis (Zoetis) Description and Business Overview
 Table 147. Abaxis (Zoetis) Point of Care Rapid Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Abaxis (Zoetis) Point of Care Rapid Diagnosis Product
 Table 149. Abaxis (Zoetis) Recent Developments/Updates
 Table 150. Ortho Clinical Diagnostics Company Information
 Table 151. Ortho Clinical Diagnostics Description and Business Overview
 Table 152. Ortho Clinical Diagnostics Point of Care Rapid Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Ortho Clinical Diagnostics Point of Care Rapid Diagnosis Product
 Table 154. Ortho Clinical Diagnostics Recent Developments/Updates
 Table 155. Phamatech Company Information
 Table 156. Phamatech Description and Business Overview
 Table 157. Phamatech Point of Care Rapid Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. Phamatech Point of Care Rapid Diagnosis Product
 Table 159. Phamatech Recent Developments/Updates
 Table 160. Chembio Diagnostics Company Information
 Table 161. Chembio Diagnostics Description and Business Overview
 Table 162. Chembio Diagnostics Point of Care Rapid Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. Chembio Diagnostics Point of Care Rapid Diagnosis Product
 Table 164. Chembio Diagnostics Recent Developments/Updates
 Table 165. Trinity Biotech Company Information
 Table 166. Trinity Biotech Description and Business Overview
 Table 167. Trinity Biotech Point of Care Rapid Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 168. Trinity Biotech Point of Care Rapid Diagnosis Product
 Table 169. Trinity Biotech Recent Developments/Updates
 Table 170. ELITech Group Company Information
 Table 171. ELITech Group Description and Business Overview
 Table 172. ELITech Group Point of Care Rapid Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 173. ELITech Group Point of Care Rapid Diagnosis Product
 Table 174. ELITech Group Recent Developments/Updates
 Table 175. Response Biomedical Company Information
 Table 176. Response Biomedical Description and Business Overview
 Table 177. Response Biomedical Point of Care Rapid Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 178. Response Biomedical Point of Care Rapid Diagnosis Product
 Table 179. Response Biomedical Recent Developments/Updates
 Table 180. Princeton BioMeditech Company Information
 Table 181. Princeton BioMeditech Description and Business Overview
 Table 182. Princeton BioMeditech Point of Care Rapid Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 183. Princeton BioMeditech Point of Care Rapid Diagnosis Product
 Table 184. Princeton BioMeditech Recent Developments/Updates
 Table 185. Alfa Wassermann Company Information
 Table 186. Alfa Wassermann Description and Business Overview
 Table 187. Alfa Wassermann Point of Care Rapid Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 188. Alfa Wassermann Point of Care Rapid Diagnosis Product
 Table 189. Alfa Wassermann Recent Developments/Updates
 Table 190. ARKRAY Company Information
 Table 191. ARKRAY Description and Business Overview
 Table 192. ARKRAY Point of Care Rapid Diagnosis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 193. ARKRAY Point of Care Rapid Diagnosis Product
 Table 194. ARKRAY Recent Developments/Updates
 Table 195. Key Raw Materials Lists
 Table 196. Raw Materials Key Suppliers Lists
 Table 197. Point of Care Rapid Diagnosis Distributors List
 Table 198. Point of Care Rapid Diagnosis Customers List
 Table 199. Point of Care Rapid Diagnosis Market Trends
 Table 200. Point of Care Rapid Diagnosis Market Drivers
 Table 201. Point of Care Rapid Diagnosis Market Challenges
 Table 202. Point of Care Rapid Diagnosis Market Restraints
 Table 203. Research Programs/Design for This Report
 Table 204. Key Data Information from Secondary Sources
 Table 205. Key Data Information from Primary Sources
 Table 206. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Point of Care Rapid Diagnosis
 Figure 2. Global Point of Care Rapid Diagnosis Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Point of Care Rapid Diagnosis Market Share by Type: 2024 & 2031
 Figure 4. Blood Glucose Testing Product Picture
 Figure 5. Blood Gas and Electrolytes Analysis Product Picture
 Figure 6. Rapid Coagulation Testing Product Picture
 Figure 7. Rapid Cardiac Markers Diagnostic Product Picture
 Figure 8. Drugs of Abuse Screening Product Picture
 Figure 9. Food Pathogens Screening Product Picture
 Figure 10. Hemoglobin Diagnostics Product Picture
 Figure 11. Infectious Disease Testing Product Picture
 Figure 12. Others Product Picture
 Figure 13. Global Point of Care Rapid Diagnosis Market Value by Application (2020-2031) & (US$ Million)
 Figure 14. Global Point of Care Rapid Diagnosis Market Share by Application: 2024 & 2031
 Figure 15. Clinics
 Figure 16. Hospitals
 Figure 17. Laboratory
 Figure 18. Others
 Figure 19. Global Point of Care Rapid Diagnosis Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 20. Global Point of Care Rapid Diagnosis Market Size (2020-2031) & (US$ Million)
 Figure 21. Global Point of Care Rapid Diagnosis Sales (2020-2031) & (K Units)
 Figure 22. Global Point of Care Rapid Diagnosis Average Price (US$/Unit) & (2020-2031)
 Figure 23. Point of Care Rapid Diagnosis Report Years Considered
 Figure 24. Point of Care Rapid Diagnosis Sales Share by Manufacturers in 2024
 Figure 25. Global Point of Care Rapid Diagnosis Revenue Share by Manufacturers in 2024
 Figure 26. Global 5 and 10 Largest Point of Care Rapid Diagnosis Players: Market Share by Revenue in Point of Care Rapid Diagnosis in 2024
 Figure 27. Point of Care Rapid Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 28. Global Point of Care Rapid Diagnosis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 29. North America Point of Care Rapid Diagnosis Sales Market Share by Country (2020-2031)
 Figure 30. North America Point of Care Rapid Diagnosis Revenue Market Share by Country (2020-2031)
 Figure 31. United States Point of Care Rapid Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Canada Point of Care Rapid Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Europe Point of Care Rapid Diagnosis Sales Market Share by Country (2020-2031)
 Figure 34. Europe Point of Care Rapid Diagnosis Revenue Market Share by Country (2020-2031)
 Figure 35. Germany Point of Care Rapid Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. France Point of Care Rapid Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. U.K. Point of Care Rapid Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Italy Point of Care Rapid Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Russia Point of Care Rapid Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Asia Pacific Point of Care Rapid Diagnosis Sales Market Share by Region (2020-2031)
 Figure 41. Asia Pacific Point of Care Rapid Diagnosis Revenue Market Share by Region (2020-2031)
 Figure 42. China Point of Care Rapid Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Japan Point of Care Rapid Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. South Korea Point of Care Rapid Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. India Point of Care Rapid Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Australia Point of Care Rapid Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. China Taiwan Point of Care Rapid Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Indonesia Point of Care Rapid Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Thailand Point of Care Rapid Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Malaysia Point of Care Rapid Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Latin America Point of Care Rapid Diagnosis Sales Market Share by Country (2020-2031)
 Figure 52. Latin America Point of Care Rapid Diagnosis Revenue Market Share by Country (2020-2031)
 Figure 53. Mexico Point of Care Rapid Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Brazil Point of Care Rapid Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Argentina Point of Care Rapid Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Middle East and Africa Point of Care Rapid Diagnosis Sales Market Share by Country (2020-2031)
 Figure 57. Middle East and Africa Point of Care Rapid Diagnosis Revenue Market Share by Country (2020-2031)
 Figure 58. Turkey Point of Care Rapid Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. Saudi Arabia Point of Care Rapid Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 60. UAE Point of Care Rapid Diagnosis Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 61. Global Sales Market Share of Point of Care Rapid Diagnosis by Type (2020-2031)
 Figure 62. Global Revenue Market Share of Point of Care Rapid Diagnosis by Type (2020-2031)
 Figure 63. Global Point of Care Rapid Diagnosis Price (US$/Unit) by Type (2020-2031)
 Figure 64. Global Sales Market Share of Point of Care Rapid Diagnosis by Application (2020-2031)
 Figure 65. Global Revenue Market Share of Point of Care Rapid Diagnosis by Application (2020-2031)
 Figure 66. Global Point of Care Rapid Diagnosis Price (US$/Unit) by Application (2020-2031)
 Figure 67. Point of Care Rapid Diagnosis Value Chain
 Figure 68. Channels of Distribution (Direct Vs Distribution)
 Figure 69. Bottom-up and Top-down Approaches for This Report
 Figure 70. Data Triangulation
 Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

RELATED REPORTS

Global Secure Hospital Communications Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4H6366
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Assisted Spine Surgery Robot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30V16581
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Direct To Consumer Telehealth Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4I2436
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Healthcare API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10N6171
Thu Sep 11 00:00:00 UTC 2025

Add to Cart